31562
中文 ｜ English 手机浏览
Research More >
Functional Protein-directed antitumor drugs: 1). Discovery and confirmation of antitumor drug new targets 2). Design of anti-tumor lead compounds based on new targets/mechanisms 3). Development of anti-tumor lead compounds based on green carrier - endogenous proteins
News More >
Feng Yang
Dr. Feng Yang currently is a professor of School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University. Dr. Yang received his Ph.D. in Fujian Institute of Material Structure, Chinese Academy of Sciences in 2005. From 2006 to 2010, he was engaged in postdoctoral research at the Energy-Brookhaven National Laboratory of the U.S. During the postdoctoral period, he participated in two major projects of the National Institutes of Health. Dr. Yang’s current research interests include 1). Discovery and confirmation of antitumor drug new targets, 2). Design of anti-tumor lead compounds based on new targets/mechanisms, 3). Development of anti-tumor lead compounds based on green carrier - endogenous proteins.
Events More >
Useful Links
You are the 31562 visitor